Ubrelvy 100 MG tablet UD 10S
Ended Awarded Last action
- Contract number
- SPE2DR26F3UQJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,283
Award facts
- Contract value 100% obligated
- $15,283.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,283.44 to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of UBRELVY 100 mg tablets in unit dose packaging (10 tablets per unit). This non-set-aside, competitively awarded delivery order is classified as a firm fixed-price contract with a completion date of January 30, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. UBRELVY (ubrogepant) is a calcitonin gene-related peptide receptor antagonist used for acute migraine treatment, representing the type of specialty pharmaceutical product that DLA procures to support military healthcare systems and veteran medical facilities.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This comprehensive IDC serves as the primary vehicle enabling AmerisourceBergen to supply a full range of pharmaceutical products, medical devices, vaccines, and specialty medications to support military treatment facilities and federal healthcare programs globally. AmerisourceBergen's position as a major pharmaceutical distributor and the broad scope of its underlying IDC demonstrate its critical role in the federal medical supply chain for defense and military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F3UQJ?
SPE2DR26F3UQJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F3UQJ worth?
The government has obligated $15,283 on SPE2DR26F3UQJ.
Is contract SPE2DR26F3UQJ an order under another contract?
Yes. SPE2DR26F3UQJ is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3UQJ competed?
The extent of competition for SPE2DR26F3UQJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award